Health

SHERIDAN, WYOMING – May 6, 2025 – In a decisive move to address one of the fastest-growing global health threats, the Global Stroke Action Coalition was launched on April 9, 2025, calling on governments worldwide to make stroke a central priority in noncommunicable disease (NCD) strategies. With the global stroke burden projected to rise by 50% over the next 25 years—claiming an estimated 100 million lives and costing USD 1.6 trillion annually—this new multi-sectoral initiative is demanding urgent, evidence-based action.

SHERIDAN, WYOMING – May 6, 2025 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has introduced its most advanced electric shaver to date: the Philips i9000 Shaver Series. With AI-powered personalization, skin-level closeness, and premium hygiene innovations, the i9000 lineup marks a significant strategic move in the high-end male grooming market.

SHERIDAN, WYOMING – May 6, 2025 – Philips has once again demonstrated its leadership in healthcare innovation with the Azurion Neuro Biplane system receiving the prestigious iF Design Gold Award 2025. Recognized for its human-centered approach and elegant integration of technology into clinical environments, the Azurion Neuro Biplane underscores Philips’ commitment to designing solutions that optimize workflows, elevate care delivery, and improve patient outcomes.

Celebrating a Decade of Design Excellence

SHERIDAN, WYOMING – May 6, 2025 – Philips has secured one of the design industry’s most coveted honors—the iF Design Gold Award 2025—for its Azurion Neuro Biplane system, marking a significant achievement in the intersection of medical technology and human-centered design. This recognition cements Philips' leadership in image-guided therapy systems and underscores its commitment to enhancing clinical precision, operational efficiency, and patient-centric innovation in healthcare environments worldwide.

SHERIDAN, WYOMING – May 6, 2025 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced key updates to its Supervisory Board composition and committee leadership ahead of its Annual General Meeting (AGM) scheduled for May 8, 2025. The adjustments, prompted by recent executive developments, aim to reinforce strategic governance while maintaining alignment with shareholder interests and regulatory best practices.

Strategic Governance Realignment Following CEO Nomination

SHERIDAN, WYOMING – May 6, 2025 – St. Luke’s University Health Network has announced a landmark investment of over $30 million in GE HealthCare’s advanced Magnetic Resonance Imaging (MRI) technology, reinforcing its commitment to cutting-edge diagnostic innovation and enhanced patient care. This strategic move by the Bethlehem, Pennsylvania-based nonprofit healthcare network is aimed at expanding access to faster, more precise imaging while significantly improving patient comfort and operational efficiency.

SHERIDAN, WYOMING – May 6, 2025 – GE HealthCare (Nasdaq: GEHC) has reported a strong start to 2025 with notable revenue and profit gains in the first quarter, signaling resilience amid global trade complexities and bolstering its long-term value proposition through innovation and strategic acquisitions.

SHERIDAN, WYOMING – May 6, 2025 – GE HealthCare (Nasdaq: GEHC) has announced a strategic expansion of its radiation oncology solutions, unveiling a suite of AI-driven technologies at the ESTRO 2025 Congress in Vienna, Austria. These developments are designed to streamline oncology workflows, accelerate treatment timelines, and improve clinical outcomes—addressing critical priorities in modern cancer care.

SHERIDAN, WYOMING – May 6, 2025 – GE HealthCare (Nasdaq: GEHC) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Aurora dual-head SPECT/CT system and Clarify DL, a Deep Learning-powered image reconstruction solution. This milestone underscores GE HealthCare’s commitment to advancing nuclear medicine by offering solutions that drive diagnostic precision, streamline workflows, and support evolving clinical needs.

SHERIDAN, WYOMING – May 5, 2025 – Siemens Healthineers has introduced its Magnetom Flow RT Pro Edition at the European Society for Radiotherapy and Oncology (ESTRO) 2025, marking a significant innovation in magnetic resonance imaging (MRI) tailored for radiation therapy. Designed for operational flexibility and clinical precision, the 1.5 Tesla system addresses longstanding challenges in integrating MRI within radiation oncology environments while offering sustainability and workflow advantages.